ETrade Capital Management’s DexCom DXCM Stock Holding History

ETrade Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.1M	Sell	10,692 -1,380	-11%	-$144K	0.02%	338
2020 Q2	$1.22M	Sell	12,072 -1,960	-14%	-$175K	0.03%	295
2020 Q1	$945K	Sell	14,032 -80	-0.6%	-$4.98K	0.02%	302
2019 Q4	$772K	Buy	14,112 +4,908	+53%	+$233K	0.02%	429
2019 Q3	$343K	Buy	+9,204	New	+$358K	0.01%	640
2017 Q3	–	Sell	-20,388	Closed	-$373K	–	714
2017 Q2	$373K	Buy	20,388 +6,768	+50%	+$125K	0.01%	521
2017 Q1	$289K	Sell	13,620 -7,244	-35%	-$141K	0.01%	538
2016 Q4	$311K	Buy	20,864 +7,884	+61%	+$140K	0.01%	466
2016 Q3	$284K	Buy	+12,980	New	+$289K	0.01%	457

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

ETrade Capital Management's DXCM Position: Q3 2020 in Review

ETrade Capital Management reduced its DexCom (DXCM) stake by 11% in Q3 2020, selling an estimated $144K and leaving 10,692 shares worth $1.1M. The position accounts for 0.02% of the portfolio, ranked #338.

ETrade Capital Management first reported a position in DXCM in Q3 2016 and has held it in 9 quarters since. The position peaked at $1.22M in Q2 2020. 728 funds tracked by Wall St. Rank hold DXCM as of Q3 2020.

ETrade Capital Management held 10,692 shares of DexCom worth $1.1M as of Q3 2020.
ETrade Capital Management sold 1,380 DexCom shares in Q3 2020, an estimated $144K.
DexCom made up 0.02% of ETrade Capital Management's portfolio in Q3 2020, its #338 holding.
ETrade Capital Management first reported a position in DexCom in Q3 2016 and has held it in 9 quarters since.
ETrade Capital Management's DexCom position peaked at $1.22M in Q2 2020.
728 funds tracked by Wall St. Rank held DexCom as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.